Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells

Yuhui Huang, Motofumi Kumazoe, Jaehoon Bae, Shuhei Yamada, Mika Takai, Shiori Hidaka, Shuya Yamashita, Yoonhee Kim, Yeongseon Won, Motoki Murata, Shuntaro Tsukamoto, Hirofumi Tachibana

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

An epidemiological study showed that green tea consumption is associated with a reduced risk of hematopoietic malignancy. The major green tea polyphenol epigallocatechin-3-O-gallate (EGCG) is reported to have anticancer effects. Chronic myeloid leukemia (CML) is a major hematopoietic malignancy characterized by expansion of myeloid cells. In the present study, we showed EGCGinduced acid sphingomyelinase (ASM) activation and lipid raft clustering in CML cells. The ASM inhibitor desipramine significantly reduced EGCG-induced cell death. Protein kinase Cδ is a well-known kinase that plays an important role in ASM activation. We observed EGCG-induced phosphorylation of protein kinase Cδ at Ser664. Importantly, EGCG-induced ASM activation was significantly reduced by pretreatment of CML cells with the soluble guanylate cyclase inhibitor NS2028, suggesting that EGCG induced ASM activation through the cyclic guanosine monophosphate (cGMP)-dependent pathway. Indeed, pharmacological inhibition of a cGMP-negative regulator enhanced the anti-CML effect of EGCG. These results indicate that EGCG-induced cell death via the cGMP/ASM pathway in CML cells.

Original languageEnglish
Pages (from-to)1162-1168
Number of pages7
JournalOncology reports
Volume34
Issue number3
DOIs
Publication statusPublished - Sep 1 2015

Fingerprint

Sphingomyelin Phosphodiesterase
Polyphenols
Tea
Myeloid Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Cell Death
Acids
Cyclic GMP
Hematologic Neoplasms
Protein Kinase C
Desipramine
epigallocatechin gallate
Cluster Analysis
Epidemiologic Studies
Phosphotransferases
Phosphorylation
Pharmacology
Lipids

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells. / Huang, Yuhui; Kumazoe, Motofumi; Bae, Jaehoon; Yamada, Shuhei; Takai, Mika; Hidaka, Shiori; Yamashita, Shuya; Kim, Yoonhee; Won, Yeongseon; Murata, Motoki; Tsukamoto, Shuntaro; Tachibana, Hirofumi.

In: Oncology reports, Vol. 34, No. 3, 01.09.2015, p. 1162-1168.

Research output: Contribution to journalArticle

Huang, Y, Kumazoe, M, Bae, J, Yamada, S, Takai, M, Hidaka, S, Yamashita, S, Kim, Y, Won, Y, Murata, M, Tsukamoto, S & Tachibana, H 2015, 'Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells', Oncology reports, vol. 34, no. 3, pp. 1162-1168. https://doi.org/10.3892/or.2015.4086
Huang, Yuhui ; Kumazoe, Motofumi ; Bae, Jaehoon ; Yamada, Shuhei ; Takai, Mika ; Hidaka, Shiori ; Yamashita, Shuya ; Kim, Yoonhee ; Won, Yeongseon ; Murata, Motoki ; Tsukamoto, Shuntaro ; Tachibana, Hirofumi. / Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells. In: Oncology reports. 2015 ; Vol. 34, No. 3. pp. 1162-1168.
@article{11ce3f713431436fa86569c6bb03c36d,
title = "Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells",
abstract = "An epidemiological study showed that green tea consumption is associated with a reduced risk of hematopoietic malignancy. The major green tea polyphenol epigallocatechin-3-O-gallate (EGCG) is reported to have anticancer effects. Chronic myeloid leukemia (CML) is a major hematopoietic malignancy characterized by expansion of myeloid cells. In the present study, we showed EGCGinduced acid sphingomyelinase (ASM) activation and lipid raft clustering in CML cells. The ASM inhibitor desipramine significantly reduced EGCG-induced cell death. Protein kinase Cδ is a well-known kinase that plays an important role in ASM activation. We observed EGCG-induced phosphorylation of protein kinase Cδ at Ser664. Importantly, EGCG-induced ASM activation was significantly reduced by pretreatment of CML cells with the soluble guanylate cyclase inhibitor NS2028, suggesting that EGCG induced ASM activation through the cyclic guanosine monophosphate (cGMP)-dependent pathway. Indeed, pharmacological inhibition of a cGMP-negative regulator enhanced the anti-CML effect of EGCG. These results indicate that EGCG-induced cell death via the cGMP/ASM pathway in CML cells.",
author = "Yuhui Huang and Motofumi Kumazoe and Jaehoon Bae and Shuhei Yamada and Mika Takai and Shiori Hidaka and Shuya Yamashita and Yoonhee Kim and Yeongseon Won and Motoki Murata and Shuntaro Tsukamoto and Hirofumi Tachibana",
year = "2015",
month = "9",
day = "1",
doi = "10.3892/or.2015.4086",
language = "English",
volume = "34",
pages = "1162--1168",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells

AU - Huang, Yuhui

AU - Kumazoe, Motofumi

AU - Bae, Jaehoon

AU - Yamada, Shuhei

AU - Takai, Mika

AU - Hidaka, Shiori

AU - Yamashita, Shuya

AU - Kim, Yoonhee

AU - Won, Yeongseon

AU - Murata, Motoki

AU - Tsukamoto, Shuntaro

AU - Tachibana, Hirofumi

PY - 2015/9/1

Y1 - 2015/9/1

N2 - An epidemiological study showed that green tea consumption is associated with a reduced risk of hematopoietic malignancy. The major green tea polyphenol epigallocatechin-3-O-gallate (EGCG) is reported to have anticancer effects. Chronic myeloid leukemia (CML) is a major hematopoietic malignancy characterized by expansion of myeloid cells. In the present study, we showed EGCGinduced acid sphingomyelinase (ASM) activation and lipid raft clustering in CML cells. The ASM inhibitor desipramine significantly reduced EGCG-induced cell death. Protein kinase Cδ is a well-known kinase that plays an important role in ASM activation. We observed EGCG-induced phosphorylation of protein kinase Cδ at Ser664. Importantly, EGCG-induced ASM activation was significantly reduced by pretreatment of CML cells with the soluble guanylate cyclase inhibitor NS2028, suggesting that EGCG induced ASM activation through the cyclic guanosine monophosphate (cGMP)-dependent pathway. Indeed, pharmacological inhibition of a cGMP-negative regulator enhanced the anti-CML effect of EGCG. These results indicate that EGCG-induced cell death via the cGMP/ASM pathway in CML cells.

AB - An epidemiological study showed that green tea consumption is associated with a reduced risk of hematopoietic malignancy. The major green tea polyphenol epigallocatechin-3-O-gallate (EGCG) is reported to have anticancer effects. Chronic myeloid leukemia (CML) is a major hematopoietic malignancy characterized by expansion of myeloid cells. In the present study, we showed EGCGinduced acid sphingomyelinase (ASM) activation and lipid raft clustering in CML cells. The ASM inhibitor desipramine significantly reduced EGCG-induced cell death. Protein kinase Cδ is a well-known kinase that plays an important role in ASM activation. We observed EGCG-induced phosphorylation of protein kinase Cδ at Ser664. Importantly, EGCG-induced ASM activation was significantly reduced by pretreatment of CML cells with the soluble guanylate cyclase inhibitor NS2028, suggesting that EGCG induced ASM activation through the cyclic guanosine monophosphate (cGMP)-dependent pathway. Indeed, pharmacological inhibition of a cGMP-negative regulator enhanced the anti-CML effect of EGCG. These results indicate that EGCG-induced cell death via the cGMP/ASM pathway in CML cells.

UR - http://www.scopus.com/inward/record.url?scp=84937199912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937199912&partnerID=8YFLogxK

U2 - 10.3892/or.2015.4086

DO - 10.3892/or.2015.4086

M3 - Article

C2 - 26135316

AN - SCOPUS:84937199912

VL - 34

SP - 1162

EP - 1168

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 3

ER -